Sagent Pharmaceuticals (SGNT) Tops Q3 EPS by 10c; Guides FY14 Revs Below Views

Go back to Sagent Pharmaceuticals (SGNT) Tops Q3 EPS by 10c; Guides FY14 Revs Below Views

Form 8-K Sagent Pharmaceuticals, For: Nov 04

November 4, 2014 8:04 AM EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

... More